| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |